日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf

通过设计针对 VEGFR2、p38α 和 B-Raf 的选择性来鉴定心脏特异性激酶 TNNI3K 的二芳脲抑制剂

Jaclyn R Patterson, Alan P Graves, Patrick Stoy, Mui Cheung, Tina A Desai, Harvey Fries, Gregory J Gatto Jr, Dennis A Holt, Lisa Shewchuk, Rachel Totoritis, Liping Wang, Lara S Kallander

Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic

小分子血清和糖皮质激素调节激酶-1 拮抗剂的开发及其作为前列腺癌治疗的评估

Andrea B Sherk, Daniel E Frigo, Christine G Schnackenberg, Jeffrey D Bray, Nicholas J Laping, Walter Trizna, Marlys Hammond, Jaclyn R Patterson, Scott K Thompson, Dmitri Kazmin, John D Norris, Donald P McDonnell